Amy Schacterle, Chief Officer of Acumen Pharmaceuticals ABOS, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $2,172. The latest trade was on 01/16.

AS

AS

Amy Schacterle

Chief Regulatory Officer

Company

Acumen Pharmaceuticals ABOS

First filing

24/11/06

Trades

6 trades

Buys / sales

0 / 1

12-month net buying

−$2,172

Last trade

01/16

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Acumen PharmaceuticalsABOS	Open-market sale	01/07	01/09	1,097 sh	$1.98	$2,172.06	−12.5%